SCHEMBL4985250

SCHEMBL4985250

Nc1ncnc2c1CCN(S(=O)(=O)c1ccc(Oc3ccncc3)cc1)C2

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
KMT2A Q03164 2/20 0.39
MKNK1 Q9BUB5 7/20 0.38
ALDH1A1 P00352 3/20 0.37
F12 P00748 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
PKM P14618 2/20 0.36
MMP1 P03956 2/20 0.35
MMP3 P08254 2/20 0.35
MMP7 P09237 2/20 0.35
MMP13 P45452 2/20 0.35
NAMPT P43490 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP14 P50281 1/20 0.35
ADAM17 P78536 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4980965 0.91 SMN1; SMN2 (0.49) LMNASMN1; SMN2KMT2AMKNK1ALDH1A1
SCHEMBL4980438 0.90 MMP1 (0.40) LMNASMN1; SMN2KMT2AMKNK1ALDH1A1
SCHEMBL4983071 0.89 PKM (0.48) LMNASMN1; SMN2MKNK1ALDH1A1TSHR
SCHEMBL4982880 0.89 L3MBTL1 (0.42) LMNASMN1; SMN2KMT2AMKNK1ALDH1A1
SCHEMBL4989425 0.87 MMP2 (0.40) LMNASMN1; SMN2KMT2AMKNK1ALDH1A1
SCHEMBL4987016 0.85 PKM (0.51) LMNASMN1; SMN2MKNK1ALDH1A1TSHR
SCHEMBL4985230 0.83 MEN1 (0.43) KMT2A
SCHEMBL4982847 0.83 LMNA (0.41) LMNASMN1; SMN2KMT2AMKNK1ALDH1A1
SCHEMBL4988452 0.82 MEN1 (0.51) SMN1; SMN2KMT2AALDH1A1F12PKM
SCHEMBL4993378 0.82 KMT2A (0.49) LMNASMN1; SMN2KMT2AMKNK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof RENOVIS, INC. 2008-02-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039478-A1 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 LMNA 1911/4885SMN1; SMN2 4369/4885KMT2A 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.